Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jessica L Schue

Biographic Data

ID7016027
NAMEJessica L Schue
GIVEN NAMESJessica L
FAMILY NAMESchue
SIGNATURESCHUE J L
AFFILIATIONSJohns Hopkins University
ORCID0000-0002-5188-5692
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
AUTHOR COUNT6
EDITOR COUNT0
FIRST PUBLICATION YEAR2024
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Pregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant

    Open Access•Rupali J Limaye, Jessica L Schue et al.•ARTICLE•PLOS Global Public Health•2026

    There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical …

  • Contextualizing future maternal RSV vaccination acceptance and trust among pregnant and lactating women in Kenya

    Open Access•Molly Sauer, Berhaun Fesshaye et al.•ARTICLE•PLOS Global Public Health•2025

    Maternal vaccination, or vaccination in pregnancy, offers a critical opportunity to provide protection to pregnant women and simultaneously confer passive immunity to infants in the first months of life, when infections are particularly serious and their immune systems are still developing. Respiratory syncytial virus (RSV) is one such serious infectious disease for newborns, but a newly approved and recommended vaccine for respiratory syncytial …

  • Trust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya

    Open Access•Jessica L Schue, Berhaun Fesshaye et al.•ARTICLE•PLOS Global Public Health•2025

    New maternal vaccines have the potential to reduce morbidity and mortality for infants from common illnesses that pose the greatest risk in the earliest phase of their life. Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections among infants under six months of age. With the recent approval of a maternal vaccine for RSV, this study aimed to understand decision-making factors among pregnant and lactating women …

  • Properties and performance of a questionnaire assessing Covid-19 vaccine knowledge and attitudes in Brazilian pregnant women

    Open Access•Bruna Maudonnet, Carla Silveira et al.•ARTICLE•BMC Public Health•2025

    The 20-item instrument demonstrated strong reliability and internal consistency, making it a valuable tool for assessing COVID-19 vaccine attitudes among pregnant women in Brazil. Its concise format may enable easier administration without compromising accuracy. Further validation could enhance its role in informing vaccination strategies and improving maternal and neonatal outcomes

  • Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines

    Open Access•Rupali J Limaye, Berhaun Fesshaye et al.•ARTICLE•Health Policy and Planning•2025

    New vaccine policy adoption is a complex process, especially in low-and-middle-income countries, requiring country policymakers to navigate challenges such as competing priorities, human and financial resource constraints, and limited logistical capacity. Since the beginning of the Expanded Programme on Immunization, most new vaccine introductions under this structure have not been aimed at adult populations. The majority of adult vaccines offere…

  • Covid-19 vaccine preferences for pregnant and lactating women in Bangladesh and Kenya

    Open Access•Jessica L Schue, Berhaun Fesshaye et al.•ARTICLE•Frontiers in Public Health•2024

    COVID-19 was responsible for more than 7 million deaths globally, as well as numerous morbidities and social and economic effects. While COVID-19 vaccines were seen as a marvel of science by the scientific community, much of the public had concerns related to COVID-19 vaccines, with certain groups—such as pregnant and lactating women—having specific concerns related to vaccine effects on their pregnancy and breast milk. In this qualitative study,…

No prominent works on this page.

  • Covid-19 vaccine preferences for pregnant and lactating women in Bangladesh and Kenya

    Open Access•Jessica L Schue, Berhaun Fesshaye et al.•ARTICLE•Frontiers in Public Health•2024

    COVID-19 was responsible for more than 7 million deaths globally, as well as numerous morbidities and social and economic effects. While COVID-19 vaccines were seen as a marvel of science by the scientific community, much of the public had concerns related to COVID-19 vaccines, with certain groups—such as pregnant and lactating women—having specific concerns related to vaccine effects on their pregnancy and breast milk. In this qualitative study,…

  • Contextualizing future maternal RSV vaccination acceptance and trust among pregnant and lactating women in Kenya

    Open Access•Molly Sauer, Berhaun Fesshaye et al.•ARTICLE•PLOS Global Public Health•2025

    Maternal vaccination, or vaccination in pregnancy, offers a critical opportunity to provide protection to pregnant women and simultaneously confer passive immunity to infants in the first months of life, when infections are particularly serious and their immune systems are still developing. Respiratory syncytial virus (RSV) is one such serious infectious disease for newborns, but a newly approved and recommended vaccine for respiratory syncytial …

  • Trust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya

    Open Access•Jessica L Schue, Berhaun Fesshaye et al.•ARTICLE•PLOS Global Public Health•2025

    New maternal vaccines have the potential to reduce morbidity and mortality for infants from common illnesses that pose the greatest risk in the earliest phase of their life. Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections among infants under six months of age. With the recent approval of a maternal vaccine for RSV, this study aimed to understand decision-making factors among pregnant and lactating women …

  • Properties and performance of a questionnaire assessing Covid-19 vaccine knowledge and attitudes in Brazilian pregnant women

    Open Access•Bruna Maudonnet, Carla Silveira et al.•ARTICLE•BMC Public Health•2025

    The 20-item instrument demonstrated strong reliability and internal consistency, making it a valuable tool for assessing COVID-19 vaccine attitudes among pregnant women in Brazil. Its concise format may enable easier administration without compromising accuracy. Further validation could enhance its role in informing vaccination strategies and improving maternal and neonatal outcomes

  • Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines

    Open Access•Rupali J Limaye, Berhaun Fesshaye et al.•ARTICLE•Health Policy and Planning•2025

    New vaccine policy adoption is a complex process, especially in low-and-middle-income countries, requiring country policymakers to navigate challenges such as competing priorities, human and financial resource constraints, and limited logistical capacity. Since the beginning of the Expanded Programme on Immunization, most new vaccine introductions under this structure have not been aimed at adult populations. The majority of adult vaccines offere…

  • Pregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant

    Open Access•Rupali J Limaye, Jessica L Schue et al.•ARTICLE•PLOS Global Public Health•2026

    There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical …

COVID-19 Impact on Reproduction (5 works) · Pregnancy (5 works) · Vaccination (5 works) · Vaccine Coverage and Hesitancy (5 works) · Pandemic (3 works) · Biology (2 works) · Environmental health (2 works) · Family medicine (2 works) · Immunization (2 works) · Immunology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae